Kurosumi M - Search Results

1

[Tolerability and safety of docetaxel plus cyclophosphamide as adjuvant chemotherapy for axillary lymph node-negative breast cancer--JECBC04 trial].

Yamamoto N, Tabei T, Inoue K, Takei H, Sato N, Yanagita Y, Fujisawa T, Fujii H, Saeki T, Kurosumi M. Yamamoto N, et al. Among authors: kurosumi m. Gan To Kagaku Ryoho. 2010 Jan;37(1):57-63. Gan To Kagaku Ryoho. 2010. PMID: 20087033 Japanese.

2

Relationship between grade of intraductal component of breast cancer within main tumor and extent of intraductal spread in surrounding tissue.

Kurosumi M, Suemasu K, Tabei T, Kuwashima Y, Takeo T, Kusawake T, Higashi Y. Kurosumi M, et al. Anticancer Res. 1998 Jul-Aug;18(4B):2869-73. Anticancer Res. 1998. PMID: 9713477

3

Establishment of histological criteria for high-risk node-negative breast carcinoma for a multi-institutional randomized clinical trial of adjuvant therapy. Japan National Surgical Adjuvant Study of Breast Cancer (NSAS-BC) Pathology Section.

Tsuda H, Akiyama F, Kurosumi M, Sakamoto G, Watanabe T. Tsuda H, et al. Among authors: kurosumi m. Jpn J Clin Oncol. 1998 Aug;28(8):486-91. doi: 10.1093/jjco/28.8.486. Jpn J Clin Oncol. 1998. PMID: 9769782 Clinical Trial.

4

[Therapeutic efficacy of pirarubicin cyclophosphamide and doxifluridine in advanced and metastatic breast cancer].

Inoue K, Tabei T, Suemasu K, Higashi Y, Kurosumi M. Inoue K, et al. Among authors: kurosumi m. Gan To Kagaku Ryoho. 1999 Apr;26(5):637-42. Gan To Kagaku Ryoho. 1999. PMID: 10234294 Clinical Trial. Japanese.

5

Enhancement of immunohistochemical reactivity for thymidine phosphorylase in breast carcinoma cells after administration of docetaxel as a neoadjuvant chemotherapy in advanced breast cancer patients.

Kurosumi M, Tabei T, Suemasu K, Inoue K, Kusawake T, Sugamata N, Higashi Y. Kurosumi M, et al. Oncol Rep. 2000 Sep-Oct;7(5):945-8. doi: 10.3892/or.7.5.945. Oncol Rep. 2000. PMID: 10948319 Clinical Trial.

6

Fibromatosis of the Breast: A Case Report.

Nagaoka H, Higashi Y, Suemasu K, Takeo T, Kurosumi M, Takei H, Iino Y, Morishita Y. Nagaoka H, et al. Among authors: kurosumi m. Breast Cancer. 1997 Jul 31;4(2):121-125. doi: 10.1007/BF02967065. Breast Cancer. 1997. PMID: 11091586

7

[A case of lung and pleural metastases from breast cancer responding to toremifene].

Inoue K, Tabei T, Kusawake T, Sugamata N, Suemasu K, Higashi Y, Kurosumi M. Inoue K, et al. Among authors: kurosumi m. Gan To Kagaku Ryoho. 2001 Feb;28(2):221-4. Gan To Kagaku Ryoho. 2001. PMID: 11242650 Japanese.

8

Relationship between existence of lymphatic invasion in peritumoral breast tissue and presence of axillary lymph node metastasis in invasive ductal carcinoma of the breast.

Kurosumi M, Suemasu K, Tabei T, Inoue K, Matsumoto H, Sugamata N, Higashi Y. Kurosumi M, et al. Oncol Rep. 2001 Sep-Oct;8(5):1051-5. doi: 10.3892/or.8.5.1051. Oncol Rep. 2001. PMID: 11496315

9

Combined effects of docetaxel and fluoropyrimidines on tumor growth and expression of interleukin-6 and thymidine phosphorylase in breast cancer xenografts.

Yamamoto S, Kurebayashi J, Kurosumi M, Kunisue H, Otsuki T, Tanaka K, Sonoo H. Yamamoto S, et al. Among authors: kurosumi m. Cancer Chemother Pharmacol. 2001 Oct;48(4):283-8. doi: 10.1007/s002800100325. Cancer Chemother Pharmacol. 2001. PMID: 11710628

10

Comparison of ELISA level and immunohistochemical status for thymidine phosphorylase (TP) in invasive breast carcinoma.

Kurosumi M, Sugamata N, Tabei T, Inoue K, Matsumoto H, Suemasu K, Higashi Y. Kurosumi M, et al. Anticancer Res. 2002 Jan-Feb;22(1A):331-8. Anticancer Res. 2002. PMID: 12017313

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

229 results

Search Page

Filters